St. Jude investigators devise new strategy likely to speed drug development for rare cancers:

St. Jude investigators devise new strategy likely to speed drug development for rare cancers: NCI Cancer Center News

Research led by St. Jude Children’s Research Hospital investigators used a pioneering approach to drug development and identified dozens of potential new treatments of ependymoma, a rare tumor of the brain and spinal cord.

Click here to read full press release from St. Jude Children’s Research Hospital .

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.